Free Trial
NASDAQ:CSCI

COSCIENS Biopharma (CSCI) Stock Price, News & Analysis

COSCIENS Biopharma logo
$3.46 +0.03 (+0.90%)
As of 07/3/2025 03:21 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About COSCIENS Biopharma Stock (NASDAQ:CSCI)

Key Stats

Today's Range
$3.31
$3.46
50-Day Range
$3.22
$3.82
52-Week Range
$1.96
$6.77
Volume
2,601 shs
Average Volume
11,278 shs
Market Capitalization
$10.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CSCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for COSCIENS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

CSCI Stock News Headlines

COSCIENS Biopharma (NASDAQ:CSCI) Trading Up 0.6% - Here's Why
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
CSCI COSCIENS Biopharma Inc.
See More Headlines

CSCI Stock Analysis - Frequently Asked Questions

COSCIENS Biopharma's stock was trading at $2.77 at the start of the year. Since then, CSCI stock has increased by 24.9% and is now trading at $3.4610.

COSCIENS Biopharma Inc. (NASDAQ:CSCI) announced its quarterly earnings data on Tuesday, May, 13th. The company reported ($1.16) earnings per share (EPS) for the quarter. The company had revenue of $1.50 million for the quarter. COSCIENS Biopharma had a negative net margin of 194.50% and a negative trailing twelve-month return on equity of 101.01%.

Shares of CSCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that COSCIENS Biopharma investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Last Earnings
5/13/2025
Today
7/04/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CSCI
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.31 million
Net Margins
-194.50%
Pretax Margin
-189.00%

Debt

Sales & Book Value

Annual Sales
$9.59 million
Price / Cash Flow
N/A
Book Value
$3.49 per share
Price / Book
0.99

Miscellaneous

Free Float
3,144,000
Market Cap
$10.90 million
Optionable
N/A
Beta
0.76
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:CSCI) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners